Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study

Lisa Eggebrecht, Juergen H. Prochaska, Andreas Schulz, Natalie Arnold, Claus Juenger, Sebastian Goebel, Dagmar Laubert-Reh, Harald Binder, Manfred E. Beutel, Nobert Pfeiffer, Stefan Blankenberg, Karl J. Lackner, Henri M. Spronk, Hugo ten Cate, Thomas Muenzel, Philipp S. Wild*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number008650
Number of pages25
JournalJournal of the American Heart Association
Volume7
Issue number17
DOIs
Publication statusPublished - 4 Sep 2018

Keywords

  • cardiovascular disease
  • oral anticoagulation
  • pharmacogenomic variants
  • vitamin K antagonists
  • MATRIX GLA-PROTEIN
  • ORAL ANTICOAGULANT
  • CALCIFICATION
  • WARFARIN
  • PROGRESSION
  • ARTERIAL
  • THERAPY
  • RISK

Cite this